Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janaye Stephens

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|July 16, 2025
Auditory corticofugal circuits drive vocalization-guided maternal behaviorAmy M LeMessurier, Gurket Kaur, Julia I Paraiso, et al.
Science Advances|March 5, 2025
Oxytocin induces embryonic diapauseJessica L Minder, Sarah B Winokur, Janaye Stephens, et al.
Journal for Immunotherapy of Cancer|December 6, 2022
Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancerYuanwang Pan, Yuan Hao, Han Han, et al.
The Journal of Clinical Investigation|January 16, 2024
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppressionAtsushi Okato, Takanobu Utsumi, Michela Ranieri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 23, 2023
Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLCHua Zhang, Christopher S Nabel, Dezhi Li, et al.
The Journal of Clinical Investigation|December 24, 2024
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer modelsDezhi Li, Ke Geng, Yuan Hao, et al.
Cancer Research|August 29, 2025
TNG260 is a Small-Molecule CoREST Inhibitor that Sensitizes STK11-Mutant Tumors to Anti-PD-1 ImmunotherapyLeanne G Ahronian, Soumyadip Sahu, Minjie Zhang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|July 16, 2025
Auditory corticofugal circuits drive vocalization-guided maternal behaviorAmy M LeMessurier, Gurket Kaur, Julia I Paraiso, et al.
Science Advances|March 5, 2025
Oxytocin induces embryonic diapauseJessica L Minder, Sarah B Winokur, Janaye Stephens, et al.
Journal for Immunotherapy of Cancer|December 6, 2022
Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancerYuanwang Pan, Yuan Hao, Han Han, et al.
The Journal of Clinical Investigation|January 16, 2024
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppressionAtsushi Okato, Takanobu Utsumi, Michela Ranieri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 23, 2023
Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLCHua Zhang, Christopher S Nabel, Dezhi Li, et al.
The Journal of Clinical Investigation|December 24, 2024
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer modelsDezhi Li, Ke Geng, Yuan Hao, et al.
Cancer Research|August 29, 2025
TNG260 is a Small-Molecule CoREST Inhibitor that Sensitizes STK11-Mutant Tumors to Anti-PD-1 ImmunotherapyLeanne G Ahronian, Soumyadip Sahu, Minjie Zhang, et al.
Pageof 1